Skip to content

Fast and Slow Metabolizers ofHoasca

James C. Callaway

Journal of Psychoactive Drugs June 1, 2005 DOI: 10.1080/02791072.2005.10399797 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational study Peer reviewed
Sample size 14
Population Experienced male members of the União do Vegetal (UDV)
Keywords Anesthesia
Citations 34
Key findings Two subgroups of CYP 2D6 phenotypes—fast and slow metabolizers of harmine—were identified among 14 experienced male members of the UDV who received a standardized dose of hoasca.

Abstract

Harmine, a major alkaloid in ayahuasca (hoasca), is a selective and reversible inhibitor of the enzyme monoamine oxidase-A (MAO-A). It is also a selective inhibitor of the human cytochrome P450 isozyme 2D6 (CYP 2D6), which metabolizes harmine to a more hydrophilic derivative for eventual excretion. CYP 2D6 exhibits a wide range of polymorphisms in human populations, and variations in this enzymatic activity could account for differences in effects between individuals who use hoasca. This report broadly describes two subgroups of CYP 2D6 phenotypes--i.e., fast and slow metabolizers of harmine-in 14 experienced male members of the União do Vegetal (UDV) who received a standardized dosage of hoasca. To compensate for metabolic variations in their normal religious practice, the administered dose of hoasca is always determined by the presiding mestre, who is responsible for deciding the actual amount for each individual. This age-old method compensates for metabolic variations between individuals and variations in both the alkaloid profile and strength of the hoasca.